Home
>
National Drug Code (NDC)
>
BOTOX
BOTOX - 0023-3921-02 - (onabotulinumtoxinA)
Drug Information of BOTOX
| Product NDC: | 0023-3921 |
| Proprietary Name: | BOTOX |
| Non Proprietary Name: | onabotulinumtoxinA |
| Active Ingredient(s): | 200 [USP'U]/1 & nbsp; onabotulinumtoxinA |
| Administration Route(s): | INTRADERMAL; INTRAMUSCULAR |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of BOTOX
| Product NDC: | 0023-3921 |
| Labeler Name: | Allergan, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103000 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20100111 |
Package Information of BOTOX
| Package NDC: | 0023-3921-02 |
| Package Description: | 1 VIAL in 1 CARTON (0023-3921-02) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
NDC Information of BOTOX
| NDC Code | 0023-3921-02 |
| Proprietary Name | BOTOX |
| Package Description | 1 VIAL in 1 CARTON (0023-3921-02) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
| Product NDC | 0023-3921 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | onabotulinumtoxinA |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRADERMAL; INTRAMUSCULAR |
| Start Marketing Date | 20100111 |
| Marketing Category Name | BLA |
| Labeler Name | Allergan, Inc. |
| Substance Name | BOTULINUM TOXIN TYPE A |
| Strength Number | 200 |
| Strength Unit | [USP'U]/1 |
| Pharmaceutical Classes | Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA] |
